Does FLIBANSERIN Cause Product use in unapproved indication? 137 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Product use in unapproved indication have been filed in association with FLIBANSERIN (ADDYI). This represents 8.0% of all adverse event reports for FLIBANSERIN.
137
Reports of Product use in unapproved indication with FLIBANSERIN
8.0%
of all FLIBANSERIN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product use in unapproved indication From FLIBANSERIN?
Of the 137 reports, 1 (0.7%) required hospitalization.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FLIBANSERIN. However, 137 reports have been filed with the FAERS database.
What Other Side Effects Does FLIBANSERIN Cause?
Drug ineffective (472)
Dizziness (298)
Nausea (176)
Somnolence (143)
Insomnia (125)
Fatigue (122)
Headache (106)
Feeling abnormal (87)
Malaise (70)
Adverse drug reaction (69)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which FLIBANSERIN Alternatives Have Lower Product use in unapproved indication Risk?
FLIBANSERIN vs FLOLAN
FLIBANSERIN vs FLUCICLOVINE F-18
FLIBANSERIN vs FLUCLOXACILLIN
FLIBANSERIN vs FLUCONAZOLE
FLIBANSERIN vs FLUCYTOSINE